Logo

Jennifer Skeen, Sue Beruti

Jan 09, 2015

BioTheranostics announced Jennifer Skeen has joined the firm as VP of clinical operations, while Sue Beruti joined the company as medical director. 

Skeen has 10 years of clinical laboratory operations management experience and was previously at Pathway Genomics, Asuragen, and Alvern Clinical Laboratories. Beruti was most recently director of pathology and medical affairs at Genoptix, where she headed the Biopharma Medical Division and medical affairs group. 

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.